Document Detail


Atenolol and amiodarone: a comparative study of their anti-ischaemic effect.
MedLine Citation:
PMID:  3132407     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A total of 10 patients with mixed angina were entered into a study to compare the anti-ischaemic efficacy of atenolol and amiodarone. The study was divided into three parts: (a) placebo for 2 weeks; (b) 100 mg atenolol given for 8 weeks; and (c) amiodarone given for 8 weeks, divided into week 1, 200 mg three times daily; week 2, 200 mg twice daily; weeks 3 and 4, 200 mg once daily; weeks 5-8, 200 mg once daily for 5 days a week. Clinical examination, basal and multi-stage effort electrocardiograms were performed at the end of each treatment. The number of anginal attacks and the amount of trinitrin taken by the patients were significantly reduced by both drugs with no significant difference between them. Compared with placebo, both drugs induced a significant increase in work capacity and in the time to decrease the ST-segment by 1 mm. At rest, atenolol reduced systolic blood pressure, heart rate and the systolic blood pressure--heart rate product compared with placebo. Systolic blood pressure was also reduced significantly compared with patients given amiodarone. Amiodarone did not influence these parameters. At maximum effort, amiodarone reduced heart rate and the systolic blood pressure--heart rate product compared with placebo. This reduction was greater for atenolol. The ST-segment depression was comparable between patients given either test drug. Amiodarone, therefore, exerts an anti-ischaemic effect similar to that shown by atenolol with different haemodynamics: atenolol reducing myocardial oxygen demand, amiodarone having an additive increase of coronary flow. Such an effect was obtained with a lower dose of amiodarone than is commonly used.
Authors:
S Ferraro; V Liguori; S Fazio; C Iacono; S Di Somma; M Petitto; M Galderisi; M Cianfrani; O de Divitiis
Related Documents :
6749347 - Clinical evaluation of endralazine (bo22708), a new vasodilator, in essential hypertens...
7011237 - Multiclinic comparison of amiloride, hydrochlorothiazide, and hydrochlorothiazide plus ...
1198087 - Effects of practolol in combination with terbutaline in the treatment of hypertension a...
2454357 - Circadian antihypertensive profile of carvedilol (bm 14190).
8378127 - Hemodynamic changes during endotracheal suctioning are mediated by increased autonomic ...
232017 - Hormonal changes with long-term converting-enzyme inhibition by captopril in essential ...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  The Journal of international medical research     Volume:  16     ISSN:  0300-0605     ISO Abbreviation:  J. Int. Med. Res.     Publication Date:    1988 Mar-Apr
Date Detail:
Created Date:  1988-07-22     Completed Date:  1988-07-22     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0346411     Medline TA:  J Int Med Res     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  114-24     Citation Subset:  IM    
Affiliation:
Department of Cardioangiology, Second Medical School, University of Naples, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amiodarone / therapeutic use*
Angina Pectoris / drug therapy
Atenolol / therapeutic use*
Coronary Disease / drug therapy*,  physiopathology
Drug Evaluation
Exercise Test
Female
Hemodynamics / drug effects
Humans
Male
Middle Aged
Nitroglycerin / therapeutic use
Chemical
Reg. No./Substance:
1951-25-3/Amiodarone; 29122-68-7/Atenolol; 55-63-0/Nitroglycerin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Presence of two strains of Neisseria gonorrhoeae in both the cervix and pharynx of a patient with di...
Next Document:  Organization and expression of a second chromosome follicle cell gene cluster in Drosophila.